525 related articles for article (PubMed ID: 19401195)
1. Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes.
Furukawa T; Nukada T; Namiki Y; Miyashita Y; Hatsuno K; Ueno Y; Yamakawa T; Isshiki T
Eur J Pharmacol; 2009 Jun; 613(1-3):100-7. PubMed ID: 19401195
[TBL] [Abstract][Full Text] [Related]
2. Selectivities of dihydropyridine derivatives in blocking Ca(2+) channel subtypes expressed in Xenopus oocytes.
Furukawa T; Yamakawa T; Midera T; Sagawa T; Mori Y; Nukada T
J Pharmacol Exp Ther; 1999 Nov; 291(2):464-73. PubMed ID: 10525060
[TBL] [Abstract][Full Text] [Related]
3. Contrasting the effects of nifedipine on subtypes of endogenous and recombinant T-type Ca2+ channels.
Shcheglovitov A; Zhelay T; Vitko Y; Osipenko V; Perez-Reyes E; Kostyuk P; Shuba Y
Biochem Pharmacol; 2005 Mar; 69(5):841-54. PubMed ID: 15710361
[TBL] [Abstract][Full Text] [Related]
4. Differential blocking action of dihydropyridine Ca2+ antagonists on a T-type Ca2+ channel (alpha1G) expressed in Xenopus oocytes.
Furukawa T; Nukada T; Miura R; Ooga K; Honda M; Watanabe S; Koganesawa S; Isshiki T
J Cardiovasc Pharmacol; 2005 Mar; 45(3):241-6. PubMed ID: 15725949
[TBL] [Abstract][Full Text] [Related]
5. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
[TBL] [Abstract][Full Text] [Related]
6. Identification of R(-)-isomer of efonidipine as a selective blocker of T-type Ca2+ channels.
Furukawa T; Miura R; Honda M; Kamiya N; Mori Y; Takeshita S; Isshiki T; Nukada T
Br J Pharmacol; 2004 Dec; 143(8):1050-7. PubMed ID: 15545287
[TBL] [Abstract][Full Text] [Related]
7. A region of N-type Ca(2+) channel critical for blockade by the dihydropyridine amlodipine.
Miyashita Y; Furukawa T; Kamegaya E; Yoshii M; Nukada T
Eur J Pharmacol; 2010 Apr; 632(1-3):14-22. PubMed ID: 20097194
[TBL] [Abstract][Full Text] [Related]
8. Block of cloned human T-type calcium channels by succinimide antiepileptic drugs.
Gomora JC; Daud AN; Weiergräber M; Perez-Reyes E
Mol Pharmacol; 2001 Nov; 60(5):1121-32. PubMed ID: 11641441
[TBL] [Abstract][Full Text] [Related]
9. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K
Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356
[TBL] [Abstract][Full Text] [Related]
10. The biochemical activation of T-type Ca2+ channels in HEK293 cells stably expressing alpha1G and Kir2.1 subunits.
Kim T; Choi J; Kim S; Kwon O; Nah SY; Han YS; Rhim H
Biochem Biophys Res Commun; 2004 Nov; 324(1):401-8. PubMed ID: 15465033
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of recombinant Ca(v)3.1 (alpha(1G)) T-type calcium channels by the antipsychotic drug clozapine.
Choi KH; Rhim H
Eur J Pharmacol; 2010 Jan; 626(2-3):123-30. PubMed ID: 19782679
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the inhibitory effect of dihydropyridines on N-type calcium channel by virtual three-dimensional pharmacophore modeling.
Ogihara T; Kano T; Kakinuma C
Arzneimittelforschung; 2009; 59(6):283-8. PubMed ID: 19634509
[TBL] [Abstract][Full Text] [Related]
13. Mammalian voltage-gated calcium channels are potently blocked by the pyrethroid insecticide allethrin.
Hildebrand ME; McRory JE; Snutch TP; Stea A
J Pharmacol Exp Ther; 2004 Mar; 308(3):805-13. PubMed ID: 14634047
[TBL] [Abstract][Full Text] [Related]
14. Ca2+ channel subtypes and pharmacology in the kidney.
Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
[TBL] [Abstract][Full Text] [Related]
15. Vascular effects of calcium channel antagonists: new evidence.
Richard S
Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
[TBL] [Abstract][Full Text] [Related]
16. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ
J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849
[TBL] [Abstract][Full Text] [Related]
17. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282
[TBL] [Abstract][Full Text] [Related]
18. State-dependent verapamil block of the cloned human Ca(v)3.1 T-type Ca(2+) channel.
Freeze BS; McNulty MM; Hanck DA
Mol Pharmacol; 2006 Aug; 70(2):718-26. PubMed ID: 16699084
[TBL] [Abstract][Full Text] [Related]
19. Voltage-dependent acceleration of Ca(v)1.2 channel current decay by (+)- and (-)-isradipine.
Berjukow S; Hering S
Br J Pharmacol; 2001 Aug; 133(7):959-66. PubMed ID: 11487504
[TBL] [Abstract][Full Text] [Related]
20. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
